967 studies found for:    Open Studies | "Connective Tissue Diseases"
Show Display Options
Rank Status Study
21 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
22 Recruiting Biomarker for Maroteaux-Lamy Disease
Conditions: Maroteaux-lamy Disease;   Lysosomal Storage Diseases
Intervention:
23 Recruiting Biomarker for Morquio Disease
Conditions: Lysosomal Storage Diseases;   Morquio Disease
Intervention:
24 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
25 Unknown  Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:
26 Unknown  Ultraviolet Light Therapy for Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Procedure: ultraviolet A-1 light treatment
27 Recruiting Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Conditions: Marfan Syndrome;   Loeys-Dietz Syndrome;   Thoracic Aortic Aneurysm and Dissection Syndromes;   Ehlers-Danlos Type IV Syndrome;   Turner Syndrome
Intervention:
28 Not yet recruiting Safety and Efficacy Study of M2951 in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: M2951;   Drug: Placebo
29 Not yet recruiting Actis Total Hip System 2 Year Follow-up
Conditions: Osteoarthritis;   Traumatic Arthritis;   Rheumatoid Arthritis;   Congenital Hip Dysplasia;   Avascular Necrosis of the Femoral Head;   Acute Traumatic Fracture of the Femoral Head or Neck;   Certain Cases of Ankylosis;   Non-union of Femoral Neck Fractures;   Certain High Sub-Capital and Femoral Neck Fractures in the Elderly
Intervention: Device: Actis Total Hip System
30 Not yet recruiting Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
Conditions: Anti-Phospholipids Syndrome (APS);   Systemic Lupus Erythematosus (SLE)
Intervention:
31 Not yet recruiting A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
Condition: Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
Interventions: Biological: MEDI7734;   Biological: Placebo
32 Recruiting A Phase 1b Study of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis
Condition: Adult-onset Rheumatoid Arthritis (RA)
Interventions: Biological: MEDI4920;   Other: Placebo
33 Recruiting Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: CELBESTA®;   Drug: CELEBREX®;   Drug: CELEBREX® placebo;   Drug: CELBESTA® placebo
34 Recruiting Therapeutic Management of Periodontitis and Clinical Manifestations of Rheumatoid Arthritis
Conditions: Periodontitis;   Rheumatoid Arthritis
Intervention: Procedure: Periodontal treatment
35 Not yet recruiting Acthar SLE (Systemic Lupus Erythematosus)
Conditions: Systemic Lupus Erythematosus (SLE);   Repository Corticotropin Injection
Interventions: Drug: Acthar low dose (40 U);   Drug: Acthar high dose (80 U)
36 Recruiting RETRO (REduction of Therapy in RA Patients in Ongoing Remission)
Condition: Rheumatoid Arthritis
Interventions: Drug: Control group;   Other: Reduction group 1;   Other: Reduction group 2
37 Recruiting Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers
Condition: Rheumatoid Arthritis
Interventions: Drug: Tocilizumab;   Drug: TNF-alpha Inhibitor
38 Not yet recruiting An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Sarilumab SAR153191 (REGN88)
39 Not yet recruiting Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CDZ173;   Drug: Placebo
40 Not yet recruiting UCB Cimzia Pregnancy Follow-up Study
Conditions: Rheumatoid Arthritis (RA);   Crohn's Disease (CD);   Psoriatic Arthritis (PsA);   Axial Spondyloarthritis and Ankylosing Spondylitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years